Tower Research Capital LLC (Trc) Shattuck Labs, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,011 shares of STTK stock, worth $3,462. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,011
Previous 3,542
14.99%
Holding current value
$3,462
Previous $13,000
23.08%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding STTK
# of Institutions
80Shares Held
28.8MCall Options Held
300Put Options Held
1.2K-
Prosight Management, LP Dallas, TX5.68MShares$6.53 Million5.32% of portfolio
-
Redmile Group, LLC San Francisco, CA5.62MShares$6.46 Million1.28% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.9MShares$3.33 Million0.02% of portfolio
-
Black Rock Inc. New York, NY2.47MShares$2.85 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.4MShares$2.76 Million0.0% of portfolio
About Shattuck Labs, Inc.
- Ticker STTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,382,000
- Market Cap $48.7M
- Description
- Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...